|
BioFire Defense
filmarray multiplex molecular diagnostic system ![]() Filmarray Multiplex Molecular Diagnostic System, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/multiplex+molecular+diagnostics/pmc06054708-6-7-6?v=BioFire+Defense Average 90 stars, based on 1 article reviews
filmarray multiplex molecular diagnostic system - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
GenMark Diagnostics
multiplex molecular diagnostics ![]() Multiplex Molecular Diagnostics, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/multiplex+molecular+diagnostics/pmc09325962-20-14-7?v=GenMark+Diagnostics Average 90 stars, based on 1 article reviews
multiplex molecular diagnostics - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Seegene Technologies
multiplexed molecular diagnostic tests ![]() Multiplexed Molecular Diagnostic Tests, supplied by Seegene Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/multiplex+molecular+diagnostics/10__1089_slash_gen__33__14__19-5-33-20?v=Seegene+Technologies Average 90 stars, based on 1 article reviews
multiplexed molecular diagnostic tests - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Qiagen
multiplex molecular diagnostic technique resplex ![]() Multiplex Molecular Diagnostic Technique Resplex, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/multiplex+molecular+diagnostics/10__1097_slash_inf__0b013e3181a51c24-7862-9-14?v=Qiagen Average 90 stars, based on 1 article reviews
multiplex molecular diagnostic technique resplex - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Journal: JMIR Public Health and Surveillance
Article Title: Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology
doi: 10.2196/publichealth.9876
Figure Lengend Snippet: Detection of respiratory panel (RP) organisms over time across all sites. Detection of FilmArray RP pathogens in the Trend dataset displayed as stacked area graphs. All data views have the same time period (July 2013 through July 2017). (First data view) Count of each organism. The test utilization rate (TUR) metric (purple line, units are FilmArray RP tests performed) and count of FilmArray RP tests that are negative (white are between pathogen count and TUR) are indicated. The y-axis values are not indicated as this is considered proprietary information. (Second data view) Pathogen detection rates for all organisms. (Third data view) Pathogen detection rates for the subset of organisms that show seasonality (see Results and the legend for the list of organisms). (Fourth data view) Human rhinovirus (HRV) or enterovirus (EV) detection rates. The CDC weighted influenza-like illness (ILI; scaled up tenfold to be visible against the pathogen data) is indicated (black line) in the third and fourth data views. Organisms follow the same color scheme in all panels; the order of organisms in the legend (down then across) matches that of the stacked area graph top to bottom.
Article Snippet: Deidentified patient test results from the
Techniques:
Journal: JMIR Public Health and Surveillance
Article Title: Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology
doi: 10.2196/publichealth.9876
Figure Lengend Snippet: Trend influenza detection rate compared with Centers for Disease and Prevention’s (CDC) influenza activity. Percent of combined FilmArray Flu A (all subtypes) and Flu B detections (blue line) and CDC-reported influenza prevalence (black lines). CDC data are aggregated only from regions with participating Trend sites.
Article Snippet: Deidentified patient test results from the
Techniques: Activity Assay